Life Science Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Life Science Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
DaVinci Biosciences LLC
Adult Stem Cell Study Demonstrates Improved Quality of Life for Patients Suffering from Spinal Cord Injury
March 31st, 2009
DaVinci Biosciences announced the publication of study results demonstrating the safety and feasibility of its acute and chronic spinal cord injury therapy platform in issue 17(12) of Cell Transplantation, a peer-reviewed journal focused on regenerative medicine. The study demonstrates that administering adult autologous bone marrow derived stem cells via multiple routes is feasible, safe, and most importantly, improves the quality of life for both acute and chronic spinal cord injury (SCI) patients. The study documents the first eight of 52 patients (four acute and four chronic) who were administered autologous bone marrow derived stem cells using a multiple route...
Source: Life Science Weekly (2009-03-31)
|
